Times Square Capital Management, LLC Vericel Corp Transaction History
Times Square Capital Management, LLC
- $6.48 Billion
- Q2 2025
A detailed history of Times Square Capital Management, LLC transactions in Vericel Corp stock. As of the latest transaction made, Times Square Capital Management, LLC holds 743,389 shares of VCEL stock, worth $27.2 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
743,389
Previous 652,465
13.94%
Holding current value
$27.2 Million
Previous $29.1 Million
8.65%
% of portfolio
0.49%
Previous 0.5%
Shares
6 transactions
Others Institutions Holding VCEL
# of Institutions
295Shares Held
54MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$294 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$130 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$103 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$90 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$89 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.72B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...